Is the action taken by catalonian primary care doctors adequate in view of the insufficient reduction in blood pressure levels in hypertensive patients? DISEHTAC-2001 study;¿Es adecuada la actitud que adoptan los médicos de atención primaria en Cataluña ante la insuficiente reducción de cifras de presión arterial en los pacientes hipertensos? Estudio DISEHTAC-2001

Atencion Primaria

Volumn 40, Issue 10, 2008, Pages 505-510

  Pérez Zamora, Susana ^a   Benítez Camps, Mencia ^b   Dalfó Baqué, Antoni ^b   Piqueras Garré, Mar ^a   Losada Duval, Gustavo ^b   Vila Coll, María Antonia ^b  

^a Centro de Salud Sagrada Familia   (Spain)

^b Centro de Atencion Primaria Gotic   (Spain)

Author keywords

Hypertension; Inadequate control; Therapeutic attitude

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; HYPERTENSION; MALE; PRIMARY MEDICAL CARE; SPAIN; SYSTOLIC BLOOD PRESSURE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; MULTICENTER STUDY; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SPAIN;

EID: 63249100290     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1157/13127231     Document Type: Article

References (26)

1. Collins R., Peto R., MacMahon S., Herbert P., Fiebach N.H., Eberlein, et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemilogical context. Lancet 335 (1990) 827-838
2. Wang J.G., and Staessen J.A. Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials. J Clin Hypertens (Greenwich) 5 (2003) 64-75
3. Bakris G.L., Williams M., and Dworkin L. Preserving renal function in adults with hypertension and diabetes: A consensus approach. National kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36 (2000) 685-761
4. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al., The National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
5. 2003 Guidelines Committee European Society of Hypertension-European Society of Cardiology Guidelines for the management of Arterial Hypertension. J Hypertens. 2003;21:1011-53.
6. Ramsay L.E., Williams B., Johnston G.D., MacGregor G.A., Poston L., Potter J.F., et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension society. J Hum Hypertens 13 (1999) 569-592
7. Feldman R.D., Campbell N., LarochelleS, Bolli P., Burguess E.D., Carruthers G., et al. 1999 Canadian recommendations for the management of hypertension. CMAJ 161 12 Suppl (1999) 1S-22S
8. World Health Organisation, International Society of Hypertension Writing Group. 2003 World Health Organisation (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21 (2003) 1983-1992
9. Ogden L.G., He J., Lydick E., and Whelton P.K. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 35 (2000) 539-543
10. a ed. (2003), Elsevier, Madrid 764-798
11. Guía pràctica Hipertensió arterial per a l'atenció primària. Segona Edició. Societat Catalana de Medicina Familiar i Comunitària (1999), EdiDe, Barcelona
12. Benítez M., Pérez Zamora S., Dalfó A., Piqueras M., Losada G., and Vila M.A. Estudio DISEHTAC II: Diagnóstico y seguimiento de la hipertensión arterial en Cataluña. Comparación con 1996. Aten Primaria 35 (2005) 7-13
13. Coca A. Evolución del control de la hipertensión arterial en España. Resultados del estudio Controlpres 2001. Hipertensión 19 (2002) 390-399
14. Banegas J.R., Rodríguez Artalejo F., Cruz J.J., Guallar P., and Rey J. Blood pressure in Spain: distribution, awareness, control and benefits of a reduction in average pressure. Hypertension 32 (1998) 998-1002
15. Armario P., Hernández R., Gasulla J.M., Alonso A., Treserres R., and Pardell A. Prevalencia de hipertensión arterial en Hospitalet de Llobregat. Evolución en la tasa de control entre 1981 y 1987. Med Clin (Barc) 94 (1990) 570-575
16. Dalfó A., Escribà J.M., Benítez M., Vila M.A., Senar E., Tovillas F.J., et al. Diagnóstico y seguimiento de la hipertensión arterial en Cataluña. Estudio DISEHTAC. Aten Primaria 28 (2001) 305-310
17. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High blood pressure. Arch Intern Med 157 (1997) 2413-2446
18. 1999 World Health Organisation International Society of Hypertension. Guidelines for the Management of Hypertension. J Hypertension 17 (1999) 151-183
19. Hyman D.J., and Pavlik V.N. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 345 (2001) 479-486
20. Llisterri Caro J.L., Rodríguez Roca G.C., Alonso Moreno F.J., Lou Arnal S., Divison Garrote J.A., Santos Rodríguez J.A., and Investigadores del Estudio PRESCAP 2002. [Blood pressure control in Spanish hypertensive patients in Primary Health Centres. PRESCAP 2002 Study]. Med Clin (Barc) 122 (2004) 165-171
21. Seculi E., Brugulat P., Medina A., Junca S., Tresserras R., and Salleras L. [Detection of cardiovascular risk factors in the reformed primary care nerwork in Catalonia. Comparison between the years 1995 and 2000]. Aten Primaria 28 (2003) 156-162
22. Coca Payeras A. Evolución del control de la hipertensión arterial en Atención Primaria en España. Resultados del estudio Controlpres 2003. Hipertensión 22 (2005) 5-14
23. Hyman D.J., and Pavlik V.N. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med 160 (2000) 2281-2286
24. Perry Jr. H.M., Davis B.R., Price T.R., Applegate W.B., Fields W.S., Guralnik J.M., et al., For the Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. Effect of treating isolated systolic hypertension n the risk of developing various types and subtypes of stroke. The Systolic Hypertension in the Elderly Program (SHEP). JAMA 284 (2000) 465-471
25. Trenkwalder P., Elmfedt D., Hofman A., Lithell H., Olofsson B., Papademetriou V., et al. The Study on Cognition and Prognosis in the Elderly (SCOPE)-major CV events and stroke in subgroups of patients. Blood Press 14 (2005) 31-37
26. The ALLHAT officers and coordinators of the ALLHAT Collaborative Research Group. Major Outcomes in High-Risk Hypertensives Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic. JAMA 288 (2002) 2981-2997